Report Details
Introduction
- Strong Market Outlook – The global allergy diagnostics market is projected to grow from USD 6.72 billion in 2024 to approximately USD 15.28 billion by 2032, advancing at an impressive CAGR of 11.1% over the forecast period.
- Rising Allergy Prevalence – Increasing cases of allergic diseases driven by environmental changes, urbanization, and lifestyle factors are fueling the demand for accurate and rapid diagnostic solutions worldwide.
- Innovation & Accessibility – Advancements in diagnostic technologies, coupled with expanding access to healthcare and greater public awareness, are driving the adoption of allergy testing across hospitals, clinics, and specialized diagnostic centers.
Risk Analysis – Global Allergy Diagnostics Market
- High Cost of Advanced Diagnostic Tests – Expensive allergy testing technologies can limit accessibility, especially in low- and middle-income regions.
- Regulatory Compliance Challenges – Stringent approval processes and varying international regulations can delay product launches and market entry.
- Shortage of Skilled Professionals – Limited availability of trained laboratory personnel may hinder the accuracy and efficiency of diagnostic services.
- Technological Obsolescence Risk – Rapid innovation in diagnostic tools may render existing systems outdated, requiring frequent investments.
- Data Privacy Concerns – Increasing adoption of digital diagnostic platforms raises the risk of patient data breaches and cybersecurity threats.
- Reimbursement Limitations – Inadequate insurance coverage for allergy testing in certain markets can restrict patient adoption rates.
- Supply Chain Vulnerabilities – Dependence on specialized reagents and equipment may lead to disruptions during global crises or raw material shortages.
Segmentation Analysis of the Global Allergy Diagnostics Market
1. By Product Type
1.1 Skin Prick Tests
1.2 Specific IgE Blood Tests
1.3 Patch Tests
1.4 Component-Resolved Diagnostics
1.5 Other Diagnostic Tests
2. By Application
2.1 Respiratory Allergies
2.2 Food Allergies
2.3 Drug Allergies
2.4 Insect Sting Allergies
2.5 Other Applications
3. By End User
3.1 Hospitals and Clinics
3.2 Diagnostic Laboratories
3.3 Research Centers
3.4 Other End Users
4. By Region – Global Allergy Diagnostics Market
4.1 North America
4.1.1 United States
4.1.2 Canada
4.2 Europe
4.2.1 Germany
4.2.2 United Kingdom
4.2.3 France
4.2.4 Italy
4.2.5 Spain
4.2.6 Rest of Europe
4.3 Asia-Pacific
4.3.1 China
4.3.2 India
4.3.3 Japan
4.3.4 South Korea
4.3.5 Australia
4.3.6 Rest of Asia-Pacific
4.4 Latin America
4.4.1 Brazil
4.4.2 Mexico
4.4.3 Rest of Latin America
4.5 Middle East and Africa
4.5.1 South Africa
4.5.2 Saudi Arabia
4.5.3 United Arab Emirates
4.5.4 Rest of Middle East and Africa
5. Key Players – Global Allergy Diagnostics Market
5.1 Thermo Fisher Scientific Inc.
5.2 Siemens Healthineers
5.3 Abbott Laboratories
5.4 BioMérieux SA
5.5 Phadia AB (part of Thermo Fisher Scientific)
5.6 Omega Diagnostics Group plc
5.7 Stallergenes Greer
5.8 Heska Corporation
5.9 Alere Inc. (now part of Abbott)
5.10 MedaPhor Group plc
5.11 Others
Table of Contents (TOC)
1. Introduction
2. Market Overview
3. Market Segmentation
3.1 By Product Type
3.1.1 Skin Prick Tests
3.1.2 Specific IgE Blood Tests
3.1.3 Patch Tests
3.1.4 Component-Resolved Diagnostics
3.1.5 Other Diagnostic Tests
3.2 By Application
3.2.1 Respiratory Allergies
3.2.2 Food Allergies
3.2.3 Drug Allergies
3.2.4 Insect Sting Allergies
3.2.5 Other Applications
3.3 By End User
3.3.1 Hospitals and Clinics
3.3.2 Diagnostic Laboratories
3.3.3 Research Centers
3.3.4 Other End Users
4. Regional Analysis
4.1 North America
4.1.1 United States
4.1.2 Canada
4.2 Europe
4.2.1 Germany
4.2.2 United Kingdom
4.2.3 France
4.2.4 Italy
4.2.5 Spain
4.2.6 Rest of Europe
4.3 Asia-Pacific
4.3.1 China
4.3.2 India
4.3.3 Japan
4.3.4 South Korea
4.3.5 Australia
4.3.6 Rest of Asia-Pacific
4.4 Latin America
4.4.1 Brazil
4.4.2 Mexico
4.4.3 Rest of Latin America
4.5 Middle East and Africa
4.5.1 South Africa
4.5.2 Saudi Arabia
4.5.3 United Arab Emirates
4.5.4 Rest of Middle East and Africa
5. Competitive Landscape
5.1 Company Profiles
5.1.1 Thermo Fisher Scientific Inc.
5.1.2 Siemens Healthineers
5.1.3 Abbott Laboratories
5.1.4 BioMérieux SA
5.1.5 Phadia AB (Thermo Fisher Scientific)
5.1.6 Omega Diagnostics Group plc
5.1.7 Stallergenes Greer
5.1.8 Heska Corporation
5.1.9 Alere Inc. (Abbott)
5.1.10 MedaPhor Group plc
6. Market Trends and Future Outlook
7. Conclusion
8. Appendices
9. References
Segmentation Analysis of the Global Allergy Diagnostics Market
1. By Product Type
1.1 Skin Prick Tests
1.2 Specific IgE Blood Tests
1.3 Patch Tests
1.4 Component-Resolved Diagnostics
1.5 Other Diagnostic Tests
2. By Application
2.1 Respiratory Allergies
2.2 Food Allergies
2.3 Drug Allergies
2.4 Insect Sting Allergies
2.5 Other Applications
3. By End User
3.1 Hospitals and Clinics
3.2 Diagnostic Laboratories
3.3 Research Centers
3.4 Other End Users
4. By Region – Global Allergy Diagnostics Market
4.1 North America
4.1.1 United States
4.1.2 Canada
4.2 Europe
4.2.1 Germany
4.2.2 United Kingdom
4.2.3 France
4.2.4 Italy
4.2.5 Spain
4.2.6 Rest of Europe
4.3 Asia-Pacific
4.3.1 China
4.3.2 India
4.3.3 Japan
4.3.4 South Korea
4.3.5 Australia
4.3.6 Rest of Asia-Pacific
4.4 Latin America
4.4.1 Brazil
4.4.2 Mexico
4.4.3 Rest of Latin America
4.5 Middle East and Africa
4.5.1 South Africa
4.5.2 Saudi Arabia
4.5.3 United Arab Emirates
4.5.4 Rest of Middle East and Africa
5. Key Players – Global Allergy Diagnostics Market
5.1 Thermo Fisher Scientific Inc.
5.2 Siemens Healthineers
5.3 Abbott Laboratories
5.4 BioMérieux SA
5.5 Phadia AB (part of Thermo Fisher Scientific)
5.6 Omega Diagnostics Group plc
5.7 Stallergenes Greer
5.8 Heska Corporation
5.9 Alere Inc. (now part of Abbott)
5.10 MedaPhor Group plc
5.11 Others
Download Sample Request Form
Make an Inquiry
Ask for Discount
Frequently Asked Questions
Why is allergy diagnostics becoming a vital tool in personalized healthcare?
Accurate allergy diagnostics enable tailored treatment plans by precisely identifying triggers, leading to improved patient outcomes, reduced symptoms, and enhanced quality of life in an era where allergies are on the rise globally.
What cutting-edge technologies are revolutionizing allergy testing in 2025?
Next-gen diagnostics leverage molecular allergy testing, component-resolved diagnostics, and point-of-care devices for faster, more sensitive, and non-invasive detection—empowering doctors with actionable insights in real time.
How is rising allergy prevalence influencing the growth of the diagnostics market worldwide?
Environmental changes, urbanization, and lifestyle shifts are driving a surge in allergic conditions, pushing demand for wider screening, early detection, and comprehensive diagnostic solutions across healthcare systems globally.
Which regions are leading the charge in allergy diagnostics adoption and innovation?
North America and Europe dominate due to advanced healthcare infrastructure and reimbursement frameworks, while Asia-Pacific is rapidly expanding, fueled by increasing awareness, rising healthcare spending, and government initiatives.
Are allergy diagnostic solutions accessible and affordable for diverse populations today?
Emerging portable and cost-effective testing kits, combined with telemedicine integration, are democratizing access to allergy diagnostics—bridging gaps in rural and underserved areas and making allergy care more inclusive.